相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Age-specific serum anti-Mullerian hormone levels: estimates from a large population-based sample
F. R. Tehrani et al.
CLIMACTERIC (2014)
Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study
Farhad Hosseinpanah et al.
CLINICAL ENDOCRINOLOGY (2014)
Membrane Estrogen Receptors: Their Role in Blood Pressure Regulation and Cardiovascular Disease
Roopashree Prabhushankar et al.
CURRENT HYPERTENSION REPORTS (2014)
Regulation of Endothelial Nitric Oxide Synthase and High-Density Lipoprotein Quality by Estradiol in Cardiovascular Pathology
Kyriakos E. Kypreos et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
A prospective, case-control study on the lipid profile and the cardiovascular risk of menopausal women on oestrogen plus progestogen therapy in a northern Italy province
Tito Silvio Patrelli et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2013)
Sex and gender differences in control of blood pressure
Rodrigo Maranon et al.
CLINICAL SCIENCE (2013)
Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials
JoAnn E. Manson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Anti-Mullerian Hormone Is Not Associated with Cardiometabolic Risk Factors in Adolescent Females
Emma L. Anderson et al.
PLOS ONE (2013)
Sex Differences in Hypertension: Contribution of the Renin-Angiotensin System
Christine Maric-Bilkan et al.
GENDER MEDICINE (2012)
Serum lipid levels in women with premature ovarian failure
Ibrahim Gulhan et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2012)
Premenopausal antimullerian hormone concentration is associated with subsequent atherosclerosis
Susan E. Appt et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2012)
HDL-C: Role as a risk modifier
Philip Barter
ATHEROSCLEROSIS SUPPLEMENTS (2011)
Is the plasma anti-Mullerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
Piotr Skalba et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2011)
Cardiovascular Disease and Risk Factors in PCOS Women of Postmenopausal Age: A 21-Year Controlled Follow-Up Study
Johanna Schmidt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Gender differences in the cardiovascular effects of sex hormones
Cristiana Vitale et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2010)
Is polycystic ovary syndrome an exception for reproductive aging?
Fahimeh Ramezani Tehrani et al.
HUMAN REPRODUCTION (2010)
The Polycystic Ovary Post-Rotterdam: A Common, Age-Dependent Finding in Ovulatory Women without Metabolic Significance
Erica B. Johnstone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Cardiovascular risk and events in polycystic ovary syndrome
E. Carmina
CLIMACTERIC (2009)
Testing ovarian reserve to predict age at menopause
C. B. Lambalk et al.
MATURITAS (2009)
Cardiovascular disease risk factors in polycystic ovary syndrome
Anuia Dokras
SEMINARS IN REPRODUCTIVE MEDICINE (2008)
A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project
H. G. Burger et al.
HUMAN REPRODUCTION UPDATE (2007)
Surgical menopause and cardiovascular risks
Rogerio A. Lobo
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2007)
Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro
I. B. Carlsson et al.
HUMAN REPRODUCTION (2006)
Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice
Marlies E. Kevenaar et al.
ENDOCRINOLOGY (2006)
Anti-Mullerian hormone: clinical insights into a promising biomarker of ovarian follicular status
Estelle Feyereisen et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2006)
Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis
F Atsma et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2006)
Anti-Mullerian hormone: a new marker for ovarian function
JA Visser et al.
REPRODUCTION (2006)
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study
IAJ van Rooij et al.
FERTILITY AND STERILITY (2005)
Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk
MC Chu et al.
HUMAN REPRODUCTION (2003)
Antimullerian hormone serum levels: a putative marker for ovarian aging
A de Vet et al.
FERTILITY AND STERILITY (2002)
Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary
ALL Durlinger et al.
ENDOCRINOLOGY (2002)
Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (Phase 1)
F Azizi et al.
SOZIAL-UND PRAVENTIVMEDIZIN (2002)
Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary
ALL Durlinger et al.
ENDOCRINOLOGY (2001)
Influence of menopause on high density lipoprotein-cholesterol and lipids
CJ Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2000)
Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study
S Wild et al.
CLINICAL ENDOCRINOLOGY (2000)
分享论文
